Clinical Trials Logo

Filter by:
NCT ID: NCT01502826 Not yet recruiting - Inflammation Clinical Trials

Mechanisms of Atherogenesis During Post-prandial Time in Childhood Obesity

Start date: February 2012
Phase: N/A
Study type: Observational

Childhood obesity is increasing at a fast pace, together with its complications. The aim of the present study is to assess several candidate triggering agents, mechanisms and intermediate phenotypes of atherosclerosis during the post-prandial phase in the obese insulin-resistant child/adolescent.

NCT ID: NCT01491243 Not yet recruiting - Clinical trials for Coronary Artery Disease

N-GAL Allows Intensive Treatment of Contrast Induced Nephropathy

NEW-MOON
Start date: January 2014
Phase: Phase 4
Study type: Interventional

Patients who undergo urgent/emergency coronary angiography can not receive any preventive treatment of contrast induced nephropathy. We tested the hypothesis that Neutrophil gelatinase-associated lipocalin (NGAL), a new biomarker predictive for AKI, allows early and effective treatment of contrast induced nephropathy in patients with urgent/emergency coronary angiography

NCT ID: NCT01491191 Not yet recruiting - Clinical trials for Chronic Post-operative Pain

Palmitoylethanolamide for Post-operative Pain Prevention

PEAforCPSP
Start date: January 2012
Phase: N/A
Study type: Interventional

Postsurgical pain becomes chronic when it lasts more then two months after surgery. A neurogenic or neuropathic pathogenesis is hypothesized for this event that reaches high rates after urologic and gynecologic surgeries. Palmitoylethanolamide (PEA) binds to mast cells and regulates pro-inflammatory factors release, without adverse events. The investigators assume that perioperative administration of PEA can reduce chronic postsurgical pain incidence of patients undergoing to urologic and gynecologic elective surgery.

NCT ID: NCT01491061 Not yet recruiting - Clinical trials for Coronary Artery Disease

Ranolazine Loading to Prevent PCI-induced Myocardial Injury

TWILIGHT
Start date: January 2014
Phase: Phase 4
Study type: Interventional

It has previously been shown that pretreatment with ranolazine 1,000 mg twice daily for 7 days can significantly reduce procedural myocardial injury in elective percutaneous coronary intervention (PCI). The investigators tested the hypothesis that twice overnight high-dose ranolazine loading before PCI can reduce the peri-procedural myocardial ischemic damage similarly to long-term pre-treatment with standard doses.

NCT ID: NCT01489202 Not yet recruiting - Clinical trials for Coronary Artery Disease

Effects of DES Platforms on Markers of Endothelial Damage and Inflammation

PLATFORM
Start date: September 2014
Phase: Phase 4
Study type: Interventional

Percutaneous coronary intervention (PCI) with stenting may induce endothelial damage/dysfunction and inflammatory reactions, which in turn delay healing and endothelialization and may lead to restenosis and atherosclerosis within the stented segments. Drugs and polymers are considered the protagonists of these pathophysiologic processes whereas the role of stent platforms remains poorly defined.It remains unknown, conversely, if stent platforms affect the extent of post-PCI endothelial damage and inflammation.

NCT ID: NCT01473277 Not yet recruiting - Stroke Clinical Trials

Botulinum Toxin Type A (BT-A) in Hemiplegic Shoulder Pain Versus Steroid

Start date: January 2012
Phase: Phase 2
Study type: Interventional

The aim of this study is to confirm the efficacy and safety of the intra-articular injection of BT-A in a multicentric double blind randomised study. For this purpose intra-articular injection of BT-A will be compared with the intra-articular steroid injection that is the current "gold standard" for the treatment of HSP.

NCT ID: NCT01441453 Not yet recruiting - Clinical trials for Hepatocellular Carcinoma

Transient Elastography in Hepatectomy for Hepatocellular Carcinoma

Start date: n/a
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether liver transient elastography performed before the surgical procedure is able to predict liver failure in patients undergoing hepatectomy for hepatocellular carcinoma.

NCT ID: NCT01440868 Not yet recruiting - Clinical trials for Respiratory Distress Syndrome

Sustained Lung Inflation in the Delivery Room in Preterm Infants at High Risk of Respiratory Distress Syndrome

SLIS
Start date: October 2011
Phase: N/A
Study type: Interventional

BACKGROUND. Sustained lung inflation (SLI) associated to an adequate PEEP may help the efficacy of the respiratory effort in lung of preterm infants at risk for respiratory distress syndrome (RDS) and reduce need of mechanical ventilation (MV). The investigators aim will be to demonstrate the hypothesis that the introduction of SLI in the delivery room protocol may reduce the need of MV in preterm infants. STUDY DESIGN: Multicenter prospective randomized controlled trial. The study will be carried out at the neonatal care units of the Careggi Infants with a gestational age between 25 and 28 weeks will be eligible and randomized at birth to receive SLI or not. Peak inflation pressure (PIP) of 25 cm H2O will be delivered for 15 seconds and then reduced to a positive end expiratory pressure (PEEP) of 5 cm H2O. Primary endpoint will be the need of MV within the first 72 hrs of life (excluding the transient tracheal intubation for surfactant replacement: e.g. INSURE). Population size: hypothesizing that SLI maneuver might decrease the need of MV during the first 72 hours of life from 35 to 20% the investigators calculated that 138 newborns must be enrolled in each groups to detect this difference statistically significant with 80% power at 0.05 level.

NCT ID: NCT01344720 Not yet recruiting - Low Back Pain Clinical Trials

Evaluation of the Efficacy and Tolerability of Etoricoxib Monotherapy Versus Combination Oxycodone-etoricoxib in Moderate to Severe Pain From Chronic Low Back Pain

Start date: May 2011
Phase: Phase 4
Study type: Interventional

This randomized, single-blind, parallel-group study will investigate the efficacy and the tolerability of a combination treatment of etoricoxib (30 mg/day) plus controlled-release oxycodone (10 mg/day) compared with a titrated dose of etoricoxib up to 60mg/day as monotherapy , in patients with Chronic Low Back Pain (CLBP) who have not responded to the starting dose of Etoricoxib 30mg/day. A common clinical question is that is it better to increase the dose of the current monotherapy or to combine both treatments early on, in patients who do not respond to standard start doses of NSAIDs like etoricoxib.

NCT ID: NCT01339325 Not yet recruiting - Cholelithiasis Clinical Trials

Laparo-endoscopic Single Site (LESS) Cholecystectomy Versus Standard LAP-CHOLE

LESSCHO
Start date: May 2011
Phase: Phase 4
Study type: Interventional

The aim of this study is to assess possible differences between the LESS approach and the standard laparoscopic approach to cholecystectomy. In particular, the Postoperative Quality of Life (QoL) will be investigated by analyzing the followings: length of hospital stay (LoS), postoperative pain, cosmetics and the results of SF 36 questionnaire. Furthermore, operative time, conversion to standard LC rate, difficulty of exposure, difficulty of dissection, and complication rate will be compared.